MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
55.18
+0.15 (0.27%)
Jul 25, 2025, 3:44 PM - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $3.50 billion as of July 25, 2025. Its market cap has increased by 24.01% in one year.
Market Cap
3.50B
Enterprise Value
3.06B
1-Year Change
24.01%
Ranking
Category
Stock Price
$55.18
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.50B, an increase of 97,243.87%. That is a compound annual growth rate of 638.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 3.49B | 2.29% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |